NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 2 filers reported holding NPS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $30,953,000 | +43.4% | 865,323 | +4.2% | 0.80% | +34.5% |
Q3 2014 | $21,581,000 | -35.6% | 830,055 | -18.2% | 0.59% | -38.1% |
Q2 2014 | $33,522,000 | +34.3% | 1,014,265 | +21.7% | 0.96% | +18.0% |
Q1 2014 | $24,953,000 | -17.2% | 833,710 | -16.0% | 0.81% | -13.4% |
Q4 2013 | $30,129,000 | +66.3% | 992,378 | +74.2% | 0.94% | +57.2% |
Q3 2013 | $18,118,000 | +107.2% | 569,550 | -1.6% | 0.60% | -74.6% |
Q2 2013 | $8,745,000 | – | 578,750 | – | 2.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 549,425 | $16,680,000 | 6.89% |
Opaleye Management Inc. | 205,000 | $5,945,000,000 | 4.67% |
Rhenman & Partners Asset Management AB | 240,000 | $7,286,000 | 2.85% |
SECTORAL ASSET MANAGEMENT INC | 1,774,919 | $53,887,000 | 2.32% |
Eventide Asset Management | 242,700 | $7,368,000 | 2.27% |
OAK RIDGE INVESTMENTS LLC | 2,713,717 | $82,389,000 | 2.16% |
First Light Asset Management, LLC | 68,245 | $2,072,000 | 1.76% |
Broadfin Capital, LLC | 400,000 | $12,144,000 | 1.60% |
Cupps Capital Management, LLC | 748,175 | $22,714,000 | 1.54% |
FCG ADVISORS, LLC | 70,651 | $2,145,000 | 1.45% |